Jürgen Geisler

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

Breast cancer research and treatment

Future oncology (London, England)

Viruses

Clinical cancer research : an official journal of the American Association for Cancer Research

Akershus University Hospital

Haukeland University Hospital (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Akershus University Hospital May 01 2008

Norway

Senior consultant :: Oncology

University of Oslo May 01 2008

Norway

Professor :: Institute of Clinical Medicine

Education History

Haukeland University Hospital Jul 01 1992 - Apr 30 2008

Norway

PHD :: Oncology

Publications

Bjørn-Erik Bertelsen, Bjørg Almås, Kamilla Fjermeros, Kristin Viste, Stephanie Beate Geisler, Torill Sauer, Knut Selsås, Jürgen Geisler
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane. Breast cancer research and treatment 206 (2) (2024)
Bjørn-Erik Bertelsen, Bjørg Almås, Kamilla Fjermeros, Kristin Viste, Stephanie Beate Geisler, Torill Sauer, Knut Selsås, Jürgen Geisler
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane. Breast cancer research and treatment 206 (2) (2024)
Leonard Schmiester, Fara Brasó-Maristany, Blanca Gonzalez-Farre, Tomás Pascual, Joaquín Gavilá, Xavier Tekpli, Jürgen Geisler, Vessela N Kristensen, Arnoldo Frigessi, Aleix Prat, Alvaro Köhn-Luque
Computational Model Predicts Patient Outcomes in Luminal B Breast Cancer Treated with Endocrine Therapy and CDK4/6 Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Bjørn-Erik Bertelsen, Bjørg Almås, Kamilla Fjermeros, Kristin Viste, Stephanie Beate Geisler, Torill Sauer, Knut Selsås, Jürgen Geisler
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane. Breast cancer research and treatment 206 (2) (2024)
Kamilla Fjermeros, Salim Ghannoum, Stephanie B Geisler, Sameer Bhargava, Andliena Tahiri, Jovana Klajic, Torben Lüders, Marie Fongård, Meh Sameen Nawaz, Tatjana Bosnjak-Olsen, Unn-Cathrin Edvardsen Buvarp, Aino Katri Johanna Rosenskiold, Nam Thi Nguyen, Tone Tysko Sletbak, Manouchehr Seyedzadeh, Knut Selsås, Alina Carmen Porojnicu, Helle Kristine Skjerven, Tone Hovda, Kristine Kleivi Sahlberg, Lilly Anne Torland, Marianne Lyngra, Clara Louise Hammarström, Elma Bahonjic Hönigsperger, John Christopher Noone, Silje Mathiassen, Antoni Hurtado, Shom Goel, Andrew Koff, Xavier Tekpli, Vessela N Kristensen, Jürgen Geisler
The NEOLETRIB trial: neoadjuvant treatment with Letrozole and Ribociclib in ER-positive, HER2-negative breast cancer. Future oncology (London, England) (2024)
Leonard Schmiester, Fara Brasó-Maristany, Blanca Gonzalez-Farre, Tomás Pascual, Joaquín Gavilá, Xavier Tekpli, Jürgen Geisler, Vessela N Kristensen, Arnoldo Frigessi, Aleix Prat, Alvaro Köhn-Luque
Computational model predicts patient outcomes in Luminal B breast cancer treated with endocrine therapy and CDK4/6 inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Bjørn-Erik Bertelsen, Bjørg Almås, Kamilla Fjermeros, Kristin Viste, Stephanie Beate Geisler, Torill Sauer, Knut Selsås, Jürgen Geisler
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane. Breast cancer research and treatment (2024)
Joel Touma, Mattia Russel Pantalone, Afsar Rahbar, Yan Liu, Katja Vetvik, Torill Sauer, Cecilia Söderberg-Naucler, Jürgen Geisler
Human Cytomegalovirus Protein Expression Is Correlated with Shorter Overall Survival in Breast Cancer Patients: A Cohort Study. Viruses 15 (3) (2023)
Joel Touma, Mattia Russel Pantalone, Afsar Rahbar, Yan Liu, Katja Vetvik, Torill Sauer, Cecilia Söderberg-Naucler, Jürgen Geisler
Human Cytomegalovirus Protein Expression Is Correlated with Shorter Overall Survival in Breast Cancer Patients: A Cohort Study. Viruses 15 (3) (2023)
Joel Touma, Mattia Russel Pantalone, Afsar Rahbar, Yan Liu, Katja Vetvik, Torill Sauer, Cecilia Söderberg-Naucler, Jürgen Geisler
Human Cytomegalovirus Protein Expression Is Correlated with Shorter Overall Survival in Breast Cancer Patients: A Cohort Study. Viruses 15 (3) (2023)
Nazli Bahrami, Shakila Jabeen, Andliena Tahiri, Torill Sauer, Hilde Presterud Ødegård, Stephanie Beate Geisler, Berit Gravdehaug, Laurens Cornelus Reitsma, Knut Selsås, Vessela Kristensen, Jürgen Geisler
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin. Breast cancer research and treatment 190 (3) (2021)
Joana Reis, Owen Thomas, Maryam Lahooti, Marianne Lyngra, Hossein Schandiz, Joao Boavida, Kjell-Inge Gjesdal, Torill Sauer, Jürgen Geisler, Jonn Terje Geitung
Correlation between MRI morphological response patterns and histopathological tumor regression after neoadjuvant endocrine therapy in locally advanced breast cancer: a randomized phase II trial. Breast cancer research and treatment 189 (3) (2021)
Joel Touma, Yan Liu, Afsar Rahbar, Mattia Russel Pantalone, Nerea Martin Almazan, Katja Vetvik, Cecilia Söderberg-Nauclér, Jürgen Geisler, Torill Sauer
Detection of Human Cytomegalovirus Proteins in Paraffin-Embedded Breast Cancer Tissue Specimens-A Novel, Automated Immunohistochemical Staining Protocol. Microorganisms 9 (5) (2021)
Jürgen Geisler, Joel Touma, Afsar Rahbar, Cecilia Söderberg-Nauclér, Katja Vetvik
A Review of the Potential Role of Human Cytomegalovirus (HCMV) Infections in Breast Cancer Carcinogenesis and Abnormal Immunity. Cancers 11 (12) (2019)
Nazli Bahrami, Torill Sauer, Siri Engebretsen, Belal Aljabri, Vahid Bemanian, Jonas Lindstrøm, Torben Lüders, Vessela Kristensen, Annika Lorentzen, Marie Loeng, Hilde Presterud Ødegård, Jan Øyvind Kvaløy, Ingeborg Berge Vestøl, Stephanie Beate Geisler, Berit Gravdehaug, Joanna Majak Gundersen, Jürgen Geisler
The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors. Future oncology (London, England) 15 (32) (2019)
Sven Tyge Langkjer, Julia Kenholm, Jeanette Dupont Jensen, Kim Wedervang, Annette Torbøl Brixen, Mie Grunnet, Lars Stenbygaard, Bjørnar Gilje, Hella Danø, Vesna Glavicic, Erik Hugger Jacobsen, Anne Sofie Brems-Eskildsen, Helle Lemvig Kruse, Trine Dongsgaard, Jeppe Neimann, Jürgen Geisler
The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer. Future oncology (London, England) 15 (22) (2019)
Vahid Bemanian, John Christopher Noone, Torill Sauer, Joel Touma, Katja Vetvik, Cecilia Søderberg-Naucler, Jonas Christoffer Lindstrøm, Ida Rashida Bukholm, Vessela N Kristensen, Jürgen Geisler
Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer. Breast cancer research and treatment 172 (2) (2018)

Jürgen Geisler.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jürgen Geisler